Your browser doesn't support javascript.
loading
[Efficacy and safety of combination therapy with chemotherapy, programmed death-1 inhibitor and anlotinib in the treatment of advanced dedifferentiated liposarcoma].
Guo, X; Zhuang, R Y; Zhou, Y H; You, C L; Zhang, Y; Feng, F; Shen, Z M; Wang, W S; Liu, Y; Zhang, H X; Tong, W Q; Lu, R K; Luo, Rongkui.
Afiliación
  • Guo X; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhuang RY; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhou YH; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • You CL; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhang Y; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Feng F; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Shen ZM; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Wang WS; Department of Medical Oncology, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Liu Y; Department of General Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhang HX; Department of General Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Tong WQ; Department of General Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Lu RK; Department of General Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Luo R; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Yi Xue Za Zhi ; 102(31): 2428-2434, 2022 Aug 23.
Article en Zh | MEDLINE | ID: mdl-36000371
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Liposarcoma Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Inhibidores de Puntos de Control Inmunológico / Liposarcoma Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China